000			02887nam a22003135i 4500
001			402597
003			ES-MaUEC
005			20240528105912.0
007			cr nn 008mamaa
008			230718s2023 sz | o |||| 0|eng d
020			_a9783031342684
024	7		_a10.1007/978-3-031-34268-4 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aR858-859.7 _b2023 EB
100	1		_aAl-Worafi, Yaser Mohammed. _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut
245	0	0	_aTechnology for Drug Safety : _bCurrent Status and Future Developments _cby Yaser Mohammed Al-Worafi
250			_a1st ed. 2023
264		1	_aCham _bSpringer International Publishing _c2023
300			_a1 recurso en línea
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aHealth Informatics _x2197-3741
505	0		_aImportance of Technology for Drug Safety -- History of Drug Safety and Technology for Drug Safety -- Electronic Registration and Medical Records for Drug Safety -- Electronic Prescriptions and orders for Drug Safety -- Computer Technologies for Drug Safety -- Internet Technologies for Drug Safety -- Artificial intelligence & Machine Learning for Drug Safety -- Mobile technologies for Drug Safety -- Social-Media for Drug Safety -- Blockchain for Drug Safety -- Technology for Drug Safety: Challenges and Recommendations.
520			_aThis book presents information about the use of technology to support the prevention and management of drug safety issues: pharmacovigilance (PV), medication errors, drug-related problems (DRPs), counterfeit medicines and other drug safety issues. Adapting new technologies/information technologies, mobile technologies and social media has contributed effectively to safety practices for medications, with this book providing comprehensive information as a guide to its challenges and potential. Technology for Drug Safety provides practicing and trainee pharmacists, pharmacy technicians, pharmacy educators, researchers, public health policy makers, healthcare professionals and medical educators with vital information about the impact of technology on drug safety-related issues. It describes the current status of the practice, the challenges in the field and recommendations for the effective use of technology in drug safety practice including clinical trials and drug development, PV, detection of adverse drug reactions, reporting and management, medication errors detection, reporting and management, DRPs, counterfeit and substandard medications, and other safety issues.
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-34268-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
988			_aSpringer_Medicine_2023
999			_c402597 _d402597